(19)
(11) EP 4 577 650 A1

(12)

(43) Date of publication:
02.07.2025 Bulletin 2025/27

(21) Application number: 23767974.1

(22) Date of filing: 25.08.2023
(51) International Patent Classification (IPC): 
C12N 15/11(2006.01)
C12N 15/113(2010.01)
C12N 9/22(2006.01)
C12N 5/0783(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/111; C12N 15/1138; C12N 2310/20; C12N 2310/315; C12N 2310/3231; C12N 2310/344; C12N 2320/51
 
C-Sets:
C12N 2310/321, C12N 2310/3521;
(86) International application number:
PCT/IB2023/058418
(87) International publication number:
WO 2024/042489 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 25.08.2022 US 202263373498 P
02.12.2022 US 202263385887 P
04.08.2023 US 202363517703 P

(71) Applicant: Life Edit Therapeutics, Inc.
Durham, NC 27701 (US)

(72) Inventors:
  • COYLE, Michael
    Chapel Hill, North Carolina 27514 (US)
  • CRAWLEY, Alexandra Briner
    Cary, North Carolina 27511 (US)
  • ELICH, Tedd D.
    Durham, North Carolina 27705 (US)
  • KELSO, Drew
    Holly Springs, North Carolina 27540 (US)
  • YU-KEMP, Hui-Chia
    Chapel Hill, North Carolina 27516 (US)
  • WILEY, David
    Hillsborough, North Carolina 27278 (US)

(74) Representative: Inspicos P/S 
Agern Allé 24
2970 Hørsholm
2970 Hørsholm (DK)

   


(54) CHEMICAL MODIFICATION OF GUIDE RNAS WITH LOCKED NUCLEIC ACID FOR RNA GUIDED NUCLEASE-MEDIATED GENE EDITING